Cherry Ventures — 2023 Investments
6 investments dated 2023 · listed companies and verified rows first · show all
Berlin-based digital recruitment marketplace matching hospitals and clinics with nurses, caregivers and other healthcare professionals.
Johannes Roggendorf(Founder)in
Co-investorsBootstrap EuropeCathay InnovationSalica InvestmentsAtlantic LabsNorthzoneQuadrille Capital
Mexican biotech developing macrocyclic antibody-mimetic proteins as mucosally delivered medical countermeasures.
HealthtechZapopan, MX
Co-investorsTechstarsAndreessen HorowitzBlockTower VCBpifranceFabric VenturesMotier Ventures
qlub provides QR-code-based pay-at-table, order-and-pay, digital menus, payment links, and a SoftPOS terminal that integrate with restaurants' POS systems.
FintechFoodTechRetail Tech
Dr. Mahmoud Fouz(Founder)in
Co-investorsHeartcore CapitalPoint NineRAED VenturesShorooq PartnersFinTech CollectiveSTV
Tacto builds AI agents for industrial procurement that connect internal data (ERP, technical drawings) with external market data to identify cost-saving potential, manage suppliers, optimize RFQ processes, and handle compliance.
Advanced ManufacturingAI & Machine LearningEnterprise Software
André Petry(Founder)inJohannes Groll(Founder)in
PartnerChristian Meermann· led
Co-investorsIndex VenturesSequoia CapitalUVC PartnersVisionaries Club
Versed creates clean skincare and makeup products using dermatologist-tested, vegan, and cruelty-free ingredients designed for sensitive skin.
ConsumerWellness & Fitness
Co-investorsAdvancit CapitalAvenir Growth CapitalBAM VenturesGreycroftSonoma Brands CapitalGradient Ventures
Weflow is a Salesforce activity-capture and revenue tool that automatically logs emails, meetings, attachments, and contacts and maps them to native Salesforce objects, and provides deal reviews, pipeline analysis, and forecasting.
AI & Machine LearningEnterprise SoftwareSaaSSales Tech
Janis Zech
Co-investorsGradient Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.